LL37 (Cathelicidin Antimicrobial Peptide) 5mg (Lyophilized Powder) For Research Use Only
LL37 is a 37-amino acid human cathelicidin antimicrobial peptide (CAMP) derived from the C-terminus of hCAP-18. It is the only human cathelicidin and has been studied for its roles in innate immunity, antimicrobial defense, wound healing, and immunomodulation.
Research suggests LL37 may exhibit broad-spectrum antibacterial and antiviral activity, pro-angiogenic effects, enhanced wound closure, and regulation of inflammatory signaling, making it of significant interest in innate immunity and regenerative medicine research.
Product Details:
Peptide: LL37 (Human Cathelicidin / hCAP-18 C-Terminal Fragment)
Purity: >98%
Form: Lyophilized powder
Quantity: 5mg per vial
Storage: Store at -4°F (-20°C). After reconstitution, refrigerate at 36°F (2–8°C) and use within 30 days.
Grade: For research purposes only. Not for human consumption, therapeutic, or diagnostic use.
Potential Research Applications:
Innate immunity and host defense peptide studies
Antimicrobial and antiviral activity research
Wound healing and pro-angiogenic biology models
Inflammatory signaling and autoimmunity investigations
For laboratory research use only. This product is not intended to diagnose, treat, cure, or prevent any disease.
